Sirolimus News and Research

RSS
PRESTIGE study suggests novel target to prevent stent thrombosis

PRESTIGE study suggests novel target to prevent stent thrombosis

Steroid-refractory chronic GVHD trial results ‘overestimate’ treatment efficacy

Steroid-refractory chronic GVHD trial results ‘overestimate’ treatment efficacy

Mayo Clinic heart transplant surgeons present findings from three clinical studies at ISHLT 2015

Mayo Clinic heart transplant surgeons present findings from three clinical studies at ISHLT 2015

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS signs agreement to acquire assets of Cappella Peel Away

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Docs who treat patients with severe LAM face agonizing treatment decision

Docs who treat patients with severe LAM face agonizing treatment decision

Santen announces Phase III results of sirolimus intravitreal injections in non-infectious posterior segment uveitis patients

Santen announces Phase III results of sirolimus intravitreal injections in non-infectious posterior segment uveitis patients

Transplant drugs may help defeat HIV

Transplant drugs may help defeat HIV

Research findings suggest new strategy in fight against HIV infection

Research findings suggest new strategy in fight against HIV infection

AB Sciex launches immunosuppressants kit to improve health care

AB Sciex launches immunosuppressants kit to improve health care

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck's NOXAFIL injection gets FDA approval for intravenous use

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck announces approval of NOXAFIL delayed-release tablets by FDA

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Svelte completes enrollment in drug-eluting coronary stent Integrated Delivery System study

Svelte completes enrollment in drug-eluting coronary stent Integrated Delivery System study

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients